Endothelium-dependent vasorelaxation in the aorta of transgenic mice expressing human apolipoprotein(a) or lipoprotein(a)

被引:7
|
作者
Rubanyi, GM [1 ]
Freay, AD
Lawn, RM
机构
[1] Berlex Biosci, Gene Therapy & Genom Dept, Richmond, CA 94804 USA
[2] Berlex Biosci, Dept Cardiovasc Res, Richmond, CA 94804 USA
[3] CV Therapeut Inc, Palo Alto, CA 94304 USA
来源
ENDOTHELIUM-NEW YORK | 2000年 / 7卷 / 04期
关键词
lipoprotein(a); apolipoprotein(a); oxidized lipoproteins; nitric oxide; LDL; endothelium; transgenic mouse;
D O I
10.3109/10623320009072212
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Elevated plasma level of lipoprotein(a) (Lp(a)) is a well established risk factor for premature atherosclerosis and coronary artery disease. Recent studies showed impaired endothelium-dependent vasodilatation in humans with elevated plasma Lp(a). However, these human studies could not determine whether (1) elevated Lp(a) levels alone are the cause of endothelial dysfunction (these patients had multiple risk factors), and (2) native or oxidatively modified Lp(a) contributes to endothelial dysfunction (no measurements of native/oxidized Lp(a) ratio was reported in humans). In order to test whether apo(a) (an essential component of Lp(a) which is required for binding to endothelial cells) and native Lp(a) cause endothelial dysfunction, in the present study we tested endothelium-dependent vasorelaxation in aortic rings isolated from control and transgenic male mice either expressing the human apo(a) gene (TgA) or both the human apo(a) and human apo B100 genes (TgL). The TgA mice had plasma apo(a) levels of 8.8 +/- 1.2mg/dl (n=6) and the double transgenic TgL mice had plasma Lp(a) levels of 15.3 +/- 1.4 mg/dl (n=8). Isolated aortic rings with and without endothelium were mounted in organ chambers and contracted with U46619 (10(-8)M) in the presence of ibuprofen (10(-5)M). Acetylcholine caused concentration-dependent (10(-9) - 10(-3)M) relaxation, which could be prevented by endothelium removal and by N-G-L-nitro-arginine (10(-4)M). Basal and acetylcholine-stimulated endothelium-dependent relaxation and endothelium-independent relaxation to nitroglycerin (10(-6)M) were not significantly different in aortic rings isolated from control and TgA or TgL mice. Twenty-four hour incubation of aortic rings isolated from control mice with recombinant human apo(a) or native Lp(a) (up to 300 mug/ml) caused no impairment of endothelium-dependent relaxations. In contrast, incubation with oxidized Lp(a) (50 mug/ml) or oxidized LDL (250 mug/ml) caused significant suppression of acetylcholine-induced endothelium-dependent vasorelaxation. These results show for the first time that elevated plasma levels of apo(a) and Lp(a) do not cause endothelial dysfunction in transgenic mice.
引用
收藏
页码:253 / 264
页数:12
相关论文
共 50 条
  • [31] Transgenic mice expressing a human apolipoprotein[a] allele
    Acquati, F
    Hammer, R
    Ercoli, B
    Mooser, V
    Tao, RX
    Rönicke, V
    Michalich, A
    Chiesa, G
    Taramelli, R
    Hobbs, HH
    Müller, HJ
    JOURNAL OF LIPID RESEARCH, 1999, 40 (06) : 994 - 1006
  • [32] ATHEROGENESIS IN TRANSGENIC MICE EXPRESSING HUMAN APOLIPOPROTEIN(A)
    LAWN, RM
    WADE, DP
    HAMMER, RE
    VERSTUYFT, JG
    RUBIN, EM
    CIRCULATION, 1992, 86 (04) : 335 - 335
  • [33] ATHEROGENESIS IN TRANSGENIC MICE EXPRESSING HUMAN APOLIPOPROTEIN(A)
    LAWN, RM
    WADE, DP
    HAMMER, RE
    CHIESA, G
    VERSTUYFT, JG
    RUBIN, EM
    NATURE, 1992, 360 (6405) : 670 - 672
  • [34] Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta
    Andriambeloson, E
    Magnier, C
    Haan-Archipoff, G
    Lobstein, A
    Anton, R
    Beretz, A
    Stoclet, JC
    Andriantsitohaina, R
    JOURNAL OF NUTRITION, 1998, 128 (12): : 2324 - 2333
  • [35] Endothelium-dependent vasorelaxation is impaired in cocaine arteriopathy
    Havranek, EP
    Nademanee, K
    Grayburn, PA
    Eichhorn, EJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (05) : 1168 - 1174
  • [36] OXIDIZED LDL IMPAIRS ENDOTHELIUM-DEPENDENT VASORELAXATION
    KUGIYAMA, K
    KERNS, S
    MORRISETT, JD
    BUCAY, M
    ROBERTS, R
    HENRY, PD
    CLINICAL RESEARCH, 1989, 37 (03): : A841 - A841
  • [37] Mechanism of endothelium-dependent vasorelaxation evoked by lysophosphatidylcholine
    Hirayama, T
    Ogawa, Y
    Tobise, K
    Kikuchi, K
    HYPERTENSION RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 21 (03): : 137 - 145
  • [38] ENDOTHELIUM-DEPENDENT BETA-ADRENOCEPTOR VASORELAXATION
    GRAVES, JE
    POSTON, L
    HYPERTENSION, 1994, 24 (03) : 392 - 392
  • [39] INHIBITION OF ENDOTHELIUM-DEPENDENT VASORELAXATION BY SICKLE ERYTHROCYTES
    MOSSERI, M
    BARTLETTPANDITE, AN
    WENC, K
    ISNER, JM
    WEINSTEIN, R
    AMERICAN HEART JOURNAL, 1993, 126 (02) : 338 - 346
  • [40] Endothelium-dependent vasorelaxation to the AMPK activator AICAR is enhanced in aorta from hypertensive rats and is NO and EDCF dependent
    Ford, Rebecca J.
    Rush, James W. E.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2011, 300 (01): : H64 - H75